| Literature DB >> 35399766 |
Marina Carvalho Prado1, Kevillin Martiniano1, Andrea Cardoso Pereira1, Karine L Cortellazzi2, Marina A Marciano1, Gabriel Abuna3, Adriana de-Jesus-Soares1.
Abstract
Aim: This study evaluated the effect of four intracanal medications commonly used in regenerative endodontic procedures on the bond strength of four calcium silicate-based materials, in which two are powder-to-liquid products (MTA and MTA-HP) and the other are ready-to-use materials (EndoSequence Root Repair Material Fast Set Putty [ERRM] and Bioceramic Repair [BIO-C Repair]).Entities:
Keywords: Bioceramic Repair; compressive strength; nonvital tooth; regenerative endodontics; root canal therapy
Year: 2022 PMID: 35399766 PMCID: PMC8989169 DOI: 10.4103/jcd.jcd_428_21
Source DB: PubMed Journal: J Conserv Dent ISSN: 0972-0707
Figure 1Flowchart of study design. Canal-like holes were prepared (Stage 1). Regenerative endodontic procedures were performed and specimens were distributed in groups according to intracanal medications and calcium silicate-based materials used (Stage 2). Push-out test was accomplished (Stage 3). NaOCl: Sodium hypochlorite solution, diH2O: Distilled water, TAP: Triple antibiotic paste, DAP: Double antibiotic paste, CH: Calcium hydroxide, CHX: Chlorhexidine
Figure 2Stereoscopic micrograph of a specimen during experiment (a-e; ×5) and representative image of fracture in SEM (f-g). (a) Initial tooth slice. (b) Canal-like holes prepared. (c) Filling of holes in the same slice with only one intracanal medication (ex: TAP). (d) Materials inserted in a clockwise direction from the mark (*): MTA (1), MTA-HP (2), ERRM (3), and BIO-C Repair (4). (e) Adhesive bond failure. (f) Canal-like hole observed in low magnification showing complete debond area around the interface. (g) In a higher magnification (inputs), the debond area is highlighted within the margins of the material (colored)
Description of intracanal medications and cervical sealing materials used in this study
| Material | Composition | Preparation |
|---|---|---|
| TAP[ | Metronidazole (400 mg), ciprofloxacin (250 mg), and minocycline (50 mg) (Drogal, Piracicaba, SP, Brazil) | The three components were homogenized in equal proportions (1:1:1) with distilled water |
| DAP[ | Metronidazole (400 mg) and ciprofloxacin (250 mg) (Drogal, Piracicaba, SP, Brazil) | The two components were homogenized in equal proportions (1:1) with distilled water |
| CH[ | Calcium hydroxide (biodinâmica, Ibiporã, PR, Brazil) | The powder was homogenized with distilled water in equal proportions (1:1) |
| CHP[ | Calcium hydroxide (Biodinâmica, Ibiporã, PR, Brazil) | The powder was homogenized with 2% chlorhexidine gel in equal proportions (1:1) |
| White MTA-2001 (MTA; Angelus, Londrina, PR, Brazil) | Powder: Tricalcium silicate (40%-60%), bismuth oxide (15%-30%), dicalcium silicate (5%-12%), tricalcium aluminate (5%-12%), tetracalcium aluminoferrite (1%-7%), calcium oxide (0%-7%)* | One powder measure (1 sachet or 1 spoon) was homogenized with 1 drop of distilled water for 30 s |
| MTA repair HP-2016 (MTA-HP; Angelus, Londrina, PR, Brazil) | Powder: Tricalcium silicate (45%-55%), calcium tungstate (20%-30%), bismuth oxide (15%-30%), dicalcium silicate (10%-15%), tricalcium aluminate (5%-12%), calcium oxide (1%-5%)* | One powder package was homogenized with two drops of the liquid for 40 s |
| ERRM-2008 (ERRM; Brasseler, Savannah, GA, USA) | Tricalcium silicate (30%-36%), zirconium oxide (15%-18%), tantalum pentoxide (12%-15%), dicalcium silicate (9%-13%), calcium sulfate (3%-8%)* | Premixed syringe ready-to-use |
| BIO-C repair-2019 (BIO-C repair; Angelus, Londrina, PR, Brazil) | Calcium silicates, calcium aluminate, calcium oxide, zirconium oxide, iron oxide, silicon dioxide, and dispersing agent (11) | Premixed syringe ready-to-use |
*Information obtained in the SDS sections of materials. SDS: Safety data sheet, TAP: Triple antibiotic paste, DAP: Double antibiotic paste, CH: Calcium hydroxide, CHP: Calcium hydroxide associated with chlorhexidine, MTA: Mineral trioxide aggregate, HP: High plasticity, ERRM: EndoSequence Root Repair Material, BIO-C Repair: Bioceramic Repair
Push-out bond strength values (mean [standard deviation]), expressed in MPa, of calcium silicate-based materials according to intracanal medications previously applied
| Intracanal medications | Total | Cervical sealing materials | |||
|---|---|---|---|---|---|
|
| |||||
| MTA | MTA-HP | ERRM | BIO-C repair | ||
| Triple antibiotic paste | 3.40 (3.19)a | 1.56 (1.50)a,B | 1.66 (1.47)a,B | 5.72 (3.74)a,A | 4.31 (3.25)a,A |
| Double antibiotic paste | 2.94 (3.00)a | 1.33 (1.22)a,B | 1.88 (2.85)a,B | 4.29 (3.85)a,A | 3.88 (2.62)a,A |
| Calcium hydroxide + diH2O | 3.64 (3.19)a | 1.77 (1.24)a,B | 0.50 (0.32)a,B | 7.70 (2.43)a,A | 4.27 (1.73)a,A |
| Calcium hydroxide + CHX | 2.75 (3.30)a | 1.17 (0.81)a,B | 0.40 (0.48)a,B | 4.95 (4.70)a,A | 4.27 (2.59)a,A |
| Total | - | 1.45 (1.17)B | 1.10 (1.65)B | 5.66 (3.84)A | 4.18 (2.51)A |
Values (MPa) followed by different letters (lower letters vertically [comparison between intracanal medications] and uppercase letters horizontally [comparison between cervical sealing materials]) are significantly different (P≤0.05). diH2O: Distilled water. CHX: Chlorhexidine, MTA: Mineral trioxide aggregate, HP: High plasticity, ERRM: EndoSequence root repair material, BIO-C Repair: Bioceramic Repair